ANATech
NMR Technologies for Glucose Monitoring
Company Overview
Snapshot
Founded in January 2012 by David Keini, ANATech operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on research and development for non-invasive medical devices.
Business overview
ANATech specializes in developing solutions based on nuclear magnetic resonance (NMR) technologies and signal-processing algorithms. The company's core focus is on creating compact, affordable devices to address real-world problems and enhance quality of life. ANATech is actively engaged in a significant R&D project to develop a non-invasive blood glucose and viscosity measurement device, targeting both clinical and home applications within the Health Tech & Life Sciences sector, specifically in medical devices and monitoring.
Log in to access full profile ›Company Intelligence Q&A
- What is ANATech's primary focus?
- ANATech focuses on developing solutions utilizing nuclear magnetic resonance technologies and signal-processing algorithms to create compact and affordable medical devices.
- What specific product is ANATech currently developing?
- ANATech is engaged in a major R&D project to develop a non-invasive blood glucose and viscosity measurement device for both clinical and home use.
- When was ANATech founded?
- ANATech was founded in January 2012.
- Who founded ANATech?
- David Keini is the founder of ANATech.
- In which sector does ANATech primarily operate?
- ANATech operates within the Health Tech & Life Sciences sector, with a focus on medical devices and monitoring.